Quotient Ltd. Announces FDA Approval of Seven Additional Blood Bank Reagents
Quotient Limited (NASDAQ: QTNT), an established, commercial-stage diagnostics company (the Company), today announced the U.S. Food and Drug Administration (FDA) has approved the...
